PCIA
OMCL icon

Prime Capital Investment Advisors’s Omnicell OMCL Stock Holding History

Prime Capital Investment Advisors’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$8K – 385
2019
Q1 		$8K Buy
+100
New +$7.49K ﹤0.01% 269

Other funds holding OMCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Prime Capital Investment Advisors's OMCL Position: Q2 2019 in Review

Prime Capital Investment Advisors sold out of Omnicell (OMCL) in Q2 2019, closing a stake of 100 shares — an estimated $8K sold.

Prime Capital Investment Advisors first reported a position in OMCL in Q1 2019 and held it in 1 quarter. The position peaked at $8K in Q1 2019. 299 funds tracked by Wall St. Rank hold OMCL as of Q2 2019.

  • Prime Capital Investment Advisors reported no remaining Omnicell position as of Q2 2019 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 100 Omnicell shares in Q2 2019, an estimated $8K.
  • Prime Capital Investment Advisors first reported a position in Omnicell in Q1 2019 and held it in 1 quarter.
  • Prime Capital Investment Advisors's Omnicell position peaked at $8K in Q1 2019.
  • 299 funds tracked by Wall St. Rank held Omnicell as of Q2 2019.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2019, filed 6 Aug 2019.